Phone:: +1 877 302 8632
Fax:: +1 888 205 9894 (Toll-free)
E-Mail:: orders@antibodies-online.com

For best experience we recommend to activate Javascript in your browser.

GAPDH antibody

GAPDH Reactivity: Human WB, IF, IHC (p), IP, ICC Host: Rabbit Polyclonal unconjugated

WB Image GAPDH antibody detects GAPDH protein by western blot analysis.

IHC-P Image GAPDH antibody detects GAPDH protein at cytoplasm in mouse testis by immunohistochemical analysis.

ICC/IF Image Confocal immunofluorescence analysis (Olympus FV10i) of paraformaldehyde-fixed HeLa, using GAPDH, antibody (green) at 1:500 dilution.

WB Image GAPDH antibody detects GAPDH protein by western blot analysis.

WB Image GAPDH antibody detects GAPDH protein by western blot analysis.

IP Image Immunoprecipitation of GAPDH protein from 293T whole cell extracts using 5 μg of GAPDH antibody, Western blot analysis was performed using GAPDH antibody, EasyBlot anti-Rabbit IgG was used as a secondary reagent.

IHC-P Image Immunohistochemical analysis of human salivary gland cancer, using GAPDH, antibody at 1:500 dilution.

WB Image GAPDH antibody detects GAPDH protein by western blot analysis.

IHC-P Image GAPDH antibody detects GAPDH protein at cytoplasm in rat heart by immunohistochemical analysis.

Immunoblotting of LEG-1 from the treated fibroblasts and the measurement of ROS within the treated fibroblasts.

Immunoblotting of LEG-1 from the treated fibroblasts and the measurement of ROS within the treated fibroblasts.

Immunoblotting of LEG-1 from the treated fibroblasts and the measurement of ROS within the treated fibroblasts.

Immunoblotting of LEG-1 from the treated fibroblasts and the measurement of ROS within the treated fibroblasts.

Effects of quercetin on the inflammatory response in H2O2-treated H9C2 cells.

Effects of quercetin on cell apoptosis in H2O2-treated H9C2 cells.

Comprehensive immunofluorescence images and immunoblotting analysis of the differentially expressed proteins identified by MALDI-TOF MS.

Gene trap screen for mitochondrial phenotypes identifies Sucla2 mutant allele.

Sucla2 mutant embryos display growth deficiency and placental mtDNA depletion.

Sucla2-deficient embryo tissues exhibit progressive, functionally significant mtDNA depletion and elevated MMA.

CM extract induces cell apoptosis.

Effects of quercetin on doxorubicin-induced changes of cell viability, cell apoptosis and cell morphology in H9C2 cells.

Representative immunoblotting and immunofluorescent analyses for selected differentially expressed proteins identified by proteomic analysis of H9C2 cells in response to doxorubicin treatment and pre-treatment with quercetin.

Representative immunoblotting and immunofluorescent analyses for selected differentially expressed proteins identified by proteomic analysis of H9C2 cells in response to doxorubicin treatment and pre-treatment with quercetin.

Representative immunoblotting and immunofluorescent analyses for selected differentially expressed proteins identified by proteomic analysis of H9C2 cells in response to doxorubicin treatment and pre-treatment with quercetin.

Representative immunoblotting and immunofluorescent analyses for selected differentially expressed proteins identified by proteomic analysis of H9C2 cells in response to doxorubicin treatment and pre-treatment with quercetin.

Representative immunoblotting and immunofluorescent analyses for selected differentially expressed proteins identified by proteomic analysis of H9C2 cells in response to doxorubicin treatment and pre-treatment with quercetin.

Representative immunoblotting and immunofluorescent analyses for selected differentially expressed proteins identified by proteomic analysis of H9C2 cells in response to doxorubicin treatment and pre-treatment with quercetin.

Representative immunoblotting and immunofluorescent analyses for selected differentially expressed proteins identified by proteomic analysis of H9C2 cells in response to doxorubicin treatment and pre-treatment with quercetin.

Representative immunoblotting and immunofluorescent analyses for selected differentially expressed proteins identified by proteomic analysis of H9C2 cells in response to doxorubicin treatment and pre-treatment with quercetin.

Representative immunoblotting and immunofluorescent analyses for selected differentially expressed proteins identified by proteomic analysis of H9C2 cells in response to doxorubicin treatment and pre-treatment with quercetin.

RAGE expression in human peripheral nerve fibers.

Arecoline induces the transdifferentiation of buccal mucosal fibroblasts (BMFs) into myofibroblasts.

Arecoline-induced α-smooth muscle actin (α-SMA) expression is mediated by the direct binding of zinc finger E-box binding homeobox 1 (ZEB1) to the α-SMA promoter.

Long-term exposure of buccal mucosal fibroblasts (BMFs) to arecoline induces fibrogenic gene expression and collagen contraction.

Long-term exposure of buccal mucosal fibroblasts (BMFs) to arecoline induces fibrogenic gene expression and collagen contraction.

Arecoline-induced zinc finger E-box binding homeobox 1 (ZEB1) expression is independent of reactive oxygen species, but is mediated by the activation of insulin-like growth factor receptor-1 (IGF-1R).

Arecoline-induced zinc finger E-box binding homeobox 1 (ZEB1) expression is independent of reactive oxygen species, but is mediated by the activation of insulin-like growth factor receptor-1 (IGF-1R).

Regulation of NED by REST in LNCaP cells.

Regulation of NED by REST in LNCaP cells.

Regulation of NED by REST in LNCaP cells.

IL-6 induces NED in LNCaP cells and this is concomitant with increased autophagy.

Knockdown of beclin1 suppresses IL-6 induced NED under androgen deprivation conditions.

Knockdown of beclin1 suppresses IL-6 induced NED under androgen deprivation conditions.

Knockdown of Atg5 suppresses IL-6 induced NED under androgen deprivation conditions.

Knockdown of Atg5 suppresses IL-6 induced NED under androgen deprivation conditions.

IL-6 treatment inhibits mTOR via the activation of AMPK pathway.

IL-6 treatment inhibits mTOR via the activation of AMPK pathway.

IL-6 treatment inhibits mTOR via the activation of AMPK pathway.

Modulation of curcumin in oxidative stress-regulating genes.

Arecoline decreased membrane expression of ZO-1 in confluent TM4 cells.

Arecoline activates ERK1/2 MAPKs and increases TNF-alpha production.

Activation of ERK1/2 MAPKs is important for TNF-alpha induction and ZO-1 protein redistribution by arecoline in TM4 cells.

DZNep-mediated sensitization to TRAIL correlates with enhanced activation of caspase signaling and involvement of the mitochondrial apoptosis pathway.

Early and accelerated processing of caspase-8 with DZNep treatment in lymphoma cell lines.

DZNep-mediated enhanced apoptosis correlates with reduced cFLIP expression levels.

DZNep-mediated enhanced apoptosis correlates with reduced cFLIP expression levels.

Effects of different proteins on post-treatment lipolysis markers.

Creation and characterization of Supt4h knockout mice.

Role of STAT3 expressionA.

Western blot analysis of FOXM1 and potential target expression in GEP-NEN cell linesAll cell lines including the non-neuroendocrine HT-29 and the FOXM1 overexpressing U2OS control cell lines expressed FOXM1 A.

Western blot analysis of FOXM1 and potential target expression in GEP-NEN cell linesAll cell lines including the non-neuroendocrine HT-29 and the FOXM1 overexpressing U2OS control cell lines expressed FOXM1 A.

Western blot analysis of FOXM1 and potential target expression in GEP-NEN cell linesAll cell lines including the non-neuroendocrine HT-29 and the FOXM1 overexpressing U2OS control cell lines expressed FOXM1 A.

Dicer inactivation in mutant mice.

The expression of BH3-only protein, pro-apoptotic proteins and anti-apoptotic proteins in LNCaP or PC3 cells after treatment with paclitaxel.

The effect of ABT-199, ABT-263 or ABT-263 in combination with paclitaxel on LNCaP or PC3 cells.

NS5 with mutation on residue 19 (M19A) showed reduced binding ability with MTP.

NS5 with mutation on residue 19 (M19A) showed reduced binding ability with MTP.

Diverse fuels promote TNKS autoPARsylation and turnover in INS-1 cells.

Promoter hypermethylation of sGCβ1 in MCF-7 and sGCα1 in MDA-MB-231 cells.

Over-expression of sGCα1 and sGCβ1 in MDA-MB-231 cells affected cGMP production, proliferation, survival, and cell cycle.

Over-expression of sGC induced apoptosis and cell cycle arrest.

HYS-32 modulates GSK3β phosphorylation.

GSK3β inhibitor SB415286 inhibits the HYS-32-induced phosphorylation of GSK3β-pY216 and attenuates the HYS-32-induced microtubule catastrophes.

Caspase-dependent apoptotic pathways were seen in LNCaP, but not in PC3 cells, in response to G2/M arrest.

LY294002 inhibits the HYS-32-induced phosphorylation of GSK3β-pS9 and GSK3β-pY216.

Overexpression of miR-29a in the murine model resulted in downregulation of fibrosis and HDAC4 in the liver of mice after BDL.

Overexpression of miR-29a in the murine model resulted in downregulation of fibrosis and HDAC4 in the liver of mice after BDL.

Effects of TLCA on HDAC4 expression in cultured primary HSCs.

Overexpression of miR-29a decreased HDAC4 expression in primary HSCs.

Overexpression of miR-29a increased histone H3 at lysine 9 (H3K9Ac) and decreased Smad3 expression in HSCs.

Overexpression of miR-29a increased histone H3 at lysine 9 (H3K9Ac) and decreased Smad3 expression in HSCs.

Western blot analysis shows pErk reduction through selumetinib treatment and by removal of stromal support.

Phospho-flow measures long-term inhibition by selumetinib of pErk generated in BCP-ALL cells by extracellular serum stimulation.

Diagnosis ALL samples differ in ability to activate Erk1/2 upon serum stimulation.

Diagnosis ALL samples differ in ability to activate Erk1/2 upon serum stimulation.

Diagnosis ALL samples differ in ability to activate Erk1/2 upon serum stimulation.

Diagnosis ALL samples differ in ability to activate Erk1/2 upon serum stimulation.

Mek pathway inhibition in combination-treated BCP-ALL cells by phospho-flow and Western blot.

Demyelination/remyelination and decreased P0 expression in dKO mice.

Loss of neurofascins and Caspr in dKO mice.

P0 interacts with neurofascins.

ETO inhibits ACT cell growth.

Inhibition of ERK1/2 inhibits ETO-induced centrosome amplification.

Chloroquine inhibits DNA damage-induced centrosome amplification.

Chloroquine inhibits ETO-activated CDK2 and ERK1/2 in adrenocortical Y1 tumor cells.

HSPs positively regulate IE2 transaction activity.

Comparison of the mRNA levels of Smad7 (a) and protein levels of Smad3 (b) expressions in the liver of WT and miR-29Tg mice following bile duct ligation (BDL).

Overexpression of miR-29a in the murine model caused the upregulation of β-catenin (a,b), and Dkk1 (d) as well as the downregulation of phospho-β-catenin (c) and GSK3β (e) in the liver of mice following bile duct ligation.

Overexpression of miR-29a in the murine model caused the upregulation of β-catenin (a,b), and Dkk1 (d) as well as the downregulation of phospho-β-catenin (c) and GSK3β (e) in the liver of mice following bile duct ligation.

Overexpression of miR-29a in the murine model caused the upregulation of β-catenin (a,b), and Dkk1 (d) as well as the downregulation of phospho-β-catenin (c) and GSK3β (e) in the liver of mice following bile duct ligation.

SFN suppressed HCV protein expression and RNA replication.

SFN-mediated HO-1 induction in HCV replicon cells.

SFN inhibited HCV replication through HO-1 dependent pathway.

SFN inhibited HCV replication through HO-1 dependent pathway.

SFN induced bilirubin production in HCV replicon cells.

SFN inhibited HCV replication by upregulating Nrf2 expression.

SFN-mediated Nrf2/HO-1 activation was PI3K dependent.

SFN-mediated Nrf2/HO-1 activation was PI3K dependent.

Hypoxia induces NED of LNCaP cells concomitant with down-regulation REST protein levels but not REST mRNA(A) LNCaP cells were treated with hypoxia (2 % O2) for 3 days.

Inhibition of neurite elongation by REST overexpression(A) LNCaP-TR-REST cells were treated with 0.

AMPK/mTOR pathway is activated by hypoxia treatment and REST knockdown(A) LNCaP cells were treated with normoxia (N) or hypoxia (H) (2 % O2) for 3 days (left panel).

Hypoxia-induced autophagy activation of LNCaP cells(A) LNCaP-eGFP-LC3 cells were treated with hypoxia (2 % O2) for 3 days.

Chemical inhibition of autophagy flux by chloroquine (CQ) suppresses hypoxia-induced NED in LNCaP cells(A) LNCaP cells were treated with hypoxia (2 % O2) in the absence or presence of 50 μM CQ for 3 days.

Knockdown of beclin 1 suppresses hypoxia-induced NED(A) LNCaP-TR-shBeclin1 cells were treated with 1 μg/mL Dox to induce beclin 1 knockdown for 4 days under normoxia and hypoxia (2 % O2).

Disruption of autophagy by treatment with CiQ derivativesA.

Disruption of autophagy by treatment with CiQ derivativesA.

Induction of apoptosis by treatment with CiQ derivativesA.

Induction of lysosome dysfunction by treatment with CiQ derivativesA and B.

Differential expression of CDK1 pTyr15 in colorectal cancer cells and tissues.

Senataxin is SUMOylated at the XY chromosomes in spermatocytes.

120 images

(105 references)

Catalog No. ABIN2857072

Datasheet as PDF

Target See all GAPDH Antibodies

GAPDH (Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH))
Reactivity
211

142

135

75

65

55

36

28

23

21

20

19

18

16

12

12

11

10

9

8

6

4

4

4

4

3

3

3

3

3

2

2

1

1

1

1

1
Human
Host
158

97

17

10

4
Rabbit
Compatible Secondaries
Clonality
179

105
Polyclonal
Conjugate
155

35

22

16

5

5

5

5

4

4

4

3

3

3

3

3

2

2

2

1

1

1

1

1
This GAPDH antibody is un-conjugated
Application
233

98

72

70

46

40

34

29

16

16

15

15

8

6

5

4

4

3

1

1

1

1

1
Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), Immunocytochemistry (ICC)

Cross-Reactivity

Bacteria, C. elegans, Chanos chanos, Chicken, Cow, Dog, Drosophila melanogaster, E. coli, Fish, Hamster, Human, Insect, Monkey, Mosquito, Mouse, Nematode, Ochotona princeps, Pig, Plant, Rabbit, Rat, Saccharomyces cerevisiae, Zebrafish (Danio rerio)

Characteristics

Rabbit Polyclonal antibody to GAPDH (glyceraldehyde-3-phosphate dehydrogenase)
GAPDH antibody

Purification

Purified by antigen-affinity chromatography.

Immunogen

Recombinant protein encompassing a sequence within the center region of human GAPDH. The exact sequence is proprietary.

Isotype

IgG
anti-Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) (AA 1-335) antibody
GAPDH Reactivity: Human, Mouse, Rat, Rabbit, Pig, Chicken, Cow, Various Species WB, IHC (p), FACS, IF (p), IF (cc), IHC (fro) Host: Rabbit Polyclonal unconjugated

anti-Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) antibody
GAPDH Reactivity: Human, Mouse, Rat WB, IF, IHC (p) Host: Mouse Monoclonal 1A10A10 unconjugated

anti-Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) (AA 62-91), (N-Term) antibody
GAPDH Reactivity: Human WB, IF, IHC (p) Host: Rabbit Polyclonal RB16537 unconjugated

anti-Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) (AA 1-335) antibody
GAPDH Reactivity: Human WB, IHC, IF, IP Host: Rabbit Polyclonal unconjugated

anti-Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) (C-Term) antibody
Verified GAPDH Reactivity: Human, Rat WB, ELISA, IHC, IF Host: Goat Polyclonal unconjugated

anti-Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) (AA 233-259), (C-Term) antibody
GAPDH Reactivity: Human WB, IF, IHC (p), FACS Host: Rabbit Polyclonal RB16543 unconjugated

anti-Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) (Internal Region) antibody
Verified GAPDH Reactivity: Human, Mouse, Rat WB, ELISA, IHC, IF Host: Goat Polyclonal unconjugated

anti-Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) (AA 226-335) antibody
GAPDH Reactivity: Human WB, ELISA Host: Mouse Monoclonal 3C2 unconjugated

anti-Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) (AA 136-335) antibody
GAPDH Reactivity: Human, Mouse, Rat WB, IHC (p) Host: Rabbit Polyclonal unconjugated

anti-Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) (AA 3-335) antibody
GAPDH Reactivity: Human WB, ELISA, IHC, IF Host: Rabbit Polyclonal unconjugated

Application Notes

WB: 1:5000-1:100000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. IP: 1:100-1:500. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.

Comment

Positive Control: PC-12 , Rat2 , Neuro 2A , C8D30 , NIH-3T3 , Raw264.7 , C2C12 , E.coli M15
Validation: Orthogonal

Restrictions

For Research Use only
Format

Liquid

Concentration

0.11 mg/mL

Buffer

1XPBS, 1 % BSA, 20 % Glycerol ( pH 7), 0.025 % ProClin 300

Preservative

ProClin

Precaution of Use

This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage

4 °C,-20 °C

Storage Comment

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
Zhang, Dai, Zhao, Wang, Dou, Zhuang, Chen, Zhao et al.: "MiR-874-3p represses the migration and invasion yet promotes the apoptosis and cisplatin sensitivity via being sponged by long intergenic non-coding RNA 00922 (LINC00922) and targeting ..." in: Bioengineered, Vol. 13, Issue 3, pp. 7082-7104, (2022) (PubMed).

Nakamura, Sato, Kobayashi, Kaneko, Ito, Soma, Okada, Miyamoto, Oya, Matsumoto, Nakamura, Kanaji, Miyamoto: "Vitamin D protects against immobilization-induced muscle atrophy via neural crest-derived cells in mice." in: Scientific reports, Vol. 10, Issue 1, pp. 12242, (2020) (PubMed).

Liao, Zhou, Zhang: "Effects of miR‑195‑5p on cell proliferation and apoptosis in gestational diabetes mellitus via targeting EZH2." in: Molecular medicine reports, Vol. 22, Issue 2, pp. 803-809, (2020) (PubMed).

Xu, Li, Wang, Wu, Wang, Chen, Deng, Zhang, Wu, Wan, Liu, Huang, Hu, Zeng, Zhou: "Mutated SASH1 promotes Mitf expression in a heterozygous mutated SASH1 knock‑in mouse model." in: International journal of molecular medicine, Vol. 46, Issue 3, pp. 1118-1134, (2020) (PubMed).

Liang, Chang, Sheu, Lin, Chung, Teng, Suk: "The Antihistamine Deptropine Induces Hepatoma Cell Death through Blocking Autophagosome-Lysosome Fusion." in: Cancers, Vol. 12, Issue 6, (2020) (PubMed).

Liu, Du, Rao, Liu, Qu: "Long non-coding RNA NPBWR1-2 affects the development of ovarian cancer via multiple microRNAs." in: Oncology letters, Vol. 20, Issue 1, pp. 685-692, (2020) (PubMed).

Chang, Kam, Chao, Zhao, Chen, Chung, Li, Wu, Lee: "Berberine Derivatives Suppress Cellular Proliferation and Tumorigenesis In Vitro in Human Non-Small-Cell Lung Cancer Cells." in: International journal of molecular sciences, Vol. 21, Issue 12, (2020) (PubMed).

Low, Lee, Lee, Wang, Chen, Chien, Li, Chang: "Reciprocal Regulation Between Indoleamine 2,3-Dioxigenase 1 and Notch1 Involved in Radiation Response of Cervical Cancer Stem Cells." in: Cancers, Vol. 12, Issue 6, (2020) (PubMed).

Möltgen, Piumatti, Massafra, Metzger, Jaehde, Kalayda: "Cisplatin Protein Binding Partners and Their Relevance for Platinum Drug Sensitivity." in: Cells, Vol. 9, Issue 6, (2020) (PubMed).

Bahraoui, Serrero, Planès: "HIV-1 Tat - TLR4/MD2 interaction drives the expression of IDO-1 in monocytes derived dendritic cells through NF-κB dependent pathway." in: Scientific reports, Vol. 10, Issue 1, pp. 8177, (2020) (PubMed).

Chen, Wu, Ho, Gung, Tsai, Orekhov, Sobenin, Lin, Yet: "Exposure to Zinc Oxide Nanoparticles Disrupts Endothelial Tight and Adherens Junctions and Induces Pulmonary Inflammatory Cell Infiltration." in: International journal of molecular sciences, Vol. 21, Issue 10, (2020) (PubMed).

Baumann, Hägele, Mochayedi, Drebant, Vent, Blobner, Noll, Nickel, Schumacher, Boos, Daniel, Wendler, Volkmar, Strobel, Offringa: "Proimmunogenic impact of MEK inhibition synergizes with agonist anti-CD40 immunostimulatory antibodies in tumor therapy." in: Nature communications, Vol. 11, Issue 1, pp. 2176, (2020) (PubMed).

Yang, Hsieh, Du, Yen, Hung: "Sequential Interferon β-Cisplatin Treatment Enhances the Surface Exposure of Calreticulin in Cancer Cells via an Interferon Regulatory Factor 1-Dependent Manner." in: Biomolecules, Vol. 10, Issue 4, (2020) (PubMed).

Wang, Yang, Liu, Chun-Kit Tong, Zhu, Malampati, Gopalkrishnashetty Sreenivasmurthy, Cheung, Iyaswamy, Su, Lu, Song, Li: "A Curcumin Derivative Activates TFEB and Protects Against Parkinsonian Neurotoxicity inVitro." in: International journal of molecular sciences, Vol. 21, Issue 4, (2020) (PubMed).

Liu, Chen, Lii, Jhuang, Huang, Li, Yao: "A Diterpenoid, 14-Deoxy-11, 12-Didehydroandrographolide, in Andrographis paniculata Reduces Steatohepatitis and Liver Injury in Mice Fed a High-Fat and High-Cholesterol Diet." in: Nutrients, Vol. 12, Issue 2, (2020) (PubMed).

Loh, Tsai, Huang, Yu, Kuo, Chao, Chou, Tsai, Lee: "Effects of Andrographolide on Intracellular pH Regulation, Cellular Migration, and Apoptosis in Human Cervical Cancer Cells †." in: Cancers, Vol. 12, Issue 2, (2020) (PubMed).

Yang, Zhu, Tong, Iyaswamy, Xie, Zhu, Sreenivasmurthy, Senthilkumar, Cheung, Song, Zhang, Li: "A stress response p38 MAP kinase inhibitor SB202190 promoted TFEB/TFE3-dependent autophagy and lysosomal biogenesis independent of p38." in: Redox biology, Vol. 32, pp. 101445, (2020) (PubMed).

Chang, Chu, Tsai, Lai, Chen: "Dopamine D3 receptor and GSK3β signaling mediate deficits in novel object recognition memory within dopamine transporter knockdown mice." in: Journal of biomedical science, Vol. 27, Issue 1, pp. 16, (2020) (PubMed).

Wang, Wang, Lin, Kao, Hung, Teng, Tsai, Chi: "Progerin in muscle leads to thermogenic and metabolic defects via impaired calcium homeostasis." in: Aging cell, Vol. 19, Issue 2, pp. e13090, (2020) (PubMed).

Huang, Chyuan, Shiue, Yu, Hsu, Hsu: "Lovastatin-mediated MCF-7 cancer cell death involves LKB1-AMPK-p38MAPK-p53-survivin signalling cascade." in: Journal of cellular and molecular medicine, Vol. 24, Issue 2, pp. 1822-1836, (2020) (PubMed).

show more references
Target

GAPDH (Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH))

Alternative Name

glyceraldehyde-3-phosphate dehydrogenase (GAPDH Products)

Synonyms

G3PD antibody, GAPD antibody, Gapd antibody, BEST:GH12586 antibody, CG12055 antibody, Dmel\\CG12055 antibody, GA3PDH antibody, GADPH antibody, GAP antibody, GAPDH antibody, GAPDH I antibody, GAPDH-1 antibody, GAPDH1 antibody, GAPDHI antibody, Gapdh antibody, Gapdh-1 antibody, Gapdh43E antibody, gadph antibody, gapdh antibody, gapdh-1 antibody, gh12586 antibody, cb609 antibody, gapd antibody, mg:bb02e05 antibody, wu:fb33a10 antibody, wu:ft80f05 antibody, KNC-NDS6 antibody, g3pd antibody, G3PDH antibody, glyceraldehyde-3-phosphate dehydrogenase antibody, Glyceraldehyde 3 phosphate dehydrogenase 1 antibody, glyceraldehyde-3-phosphate dehydrogenase S homeolog antibody, glyceraldehyde-3-phosphate dehydrogenase, type I antibody, olfactory receptor 8K3 antibody, GAPDH antibody, Gapdh antibody, Gapdh1 antibody, gapdh antibody, gapdh.S antibody, gapDH antibody, LOC100404960 antibody, LOC614985 antibody

Background

The product of this gene catalyzes an important energy-yielding step in carbohydrate metabolism, the reversible oxidative phosphorylation of glyceraldehyde-3-phosphate in the presence of inorganic phosphate and nicotinamide adenine dinucleotide (NAD). The enzyme exists as a tetramer of identical chains. Many pseudogenes similar to this locus are present in the human genome.

Cellular Localization: Cytoplasm , perinuclear region , Membrane

Molecular Weight

36 kDa

Gene ID

2597

UniProt

P04406

You are here: